Wilson Sonsini Goodrich & Rosati advised Sana Biotechnology on the offering, and Cooley advised the underwriters. Sana Biotechnology, Inc. (Nasdaq: SANA) announced the closing of its...
Sana Biotechnology’s $189.75 Million Upsized Follow-On Offering
Sana’s Series B Financing Round
DLA Piper advised Sana on the deal. Sana completed a Series B extension financing in which the Company landed approximately USD 28 million from New Enterprise...